Antibody-Drug Conjugates (ADCs) are a fundamental technology in modern tumor-targeted therapy with their ‘tripartite integrated design’ of ‘precision carrier - stable linker - potent payload’: The ...
Fluorescence imaging offers robust, multi-parametric and scalable analysis of cell-level activity in heterogenous populations with excellent spatial and temporal resolution. This seminar will provide ...
Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...
CD37, a surface protein present on most acute myeloid leukemia (AML) blasts, demonstrates unique internalization properties that enable targeted drug delivery with minimal impact on normal blood cells ...
In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...
The MarketWatch News Department was not involved in the creation of this content. CUSABIO Launches DT3C to Streamline Antibody Screening and Enhance ADC Research HOUSTON, March 7, 2025 ...
Cell-Based Assay Platforms are Evolving to Meet Diverse Challenges Cell-based assay platforms are evolving to meet diverse challenges—mimicking disease states, preserving signaling pathways, modeling ...
G protein-coupled receptors (GPCR) are a large and diverse class of plasma membrane receptors involved in transduction of extracellular signals. The range of GPCR ligands is broad and includes small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback